ClinicalTrials.Veeva

Menu

"Remind to Move" Treatment Versus Constraint-induced Movement Therapy for Children With Hemiplegic Cerebral Palsy

T

The Hong Kong Polytechnic University

Status

Completed

Conditions

Upper Extremity Hemiplegia
Hemiplegic Cerebral Palsy

Treatments

Behavioral: Remind-to-move
Behavioral: Conventional rehabilitation
Behavioral: Modified constraint induced movement therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02645331
HSEARS20130214003

Details and patient eligibility

About

The aim of this study was to determine the effects of an innovative child-friendly remind-to-move treatment (RTM) treatment by comparing it with constraint-induced movement therapy (CIMT) on upper extremity outcomes in children with hemiplegic Cerebral Palsy. In an evaluator-blinded randomized controlled trial, 73 children, among of whom 20 in Manual Ability Classification System level I, 38 level II, and 15 level III, were recruited from 3 special schools and randomized to receive 75-hour RTM (n=25) and CIMT (n=24) programme over 15-weekdays, and conventional treatment (n=24). The primary outcomes were Jebsen-Taylor Hand Function Test (JTHFT) and Bruininks-Oseretsky Test of Motor Proficiency (BOTMP-II) Subtest 3 for assessing the motor efficiency at baseline, posttest, and 1- and 3-month follow-up.

Enrollment

73 patients

Sex

All

Ages

5 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Hemiplegic Cerebral Palsy
  • Aged 5 to 16 years
  • Ability to follow instructions
  • Ability to grasp and release light objects, and at least 20° wrist and 10°fingers in metacarpophalangeal joints extension from full flexion for the affected hand
  • Manual Activity Classification System (MACS) 19 grades I, II or III of the affected hand

Exclusion criteria

  • Severe cognitive, visual, or auditory disorder
  • Seizure and health problems not associated with cerebral palsy
  • Predominant spasticity or contracture grades more than 3 of Modified Ashworth Scale 20 on wrist and finger flexors, forearm pronators and ⁄ or thumb adductors
  • Receiving new pharmaceutical (i.e. botulinum toxin injections) and/or surgical interventions within 6-month before study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

73 participants in 3 patient groups, including a placebo group

Remind-to-move
Experimental group
Description:
RTM involved a wristwatch device worn on more-affected arm which emitted sensory cueing continuously to remind the children to use the more-affected hand to engage in daily activities or complete bimanual tasks intensively, 5 hour per day, 5 days every week, for 3 consecutive weeks.
Treatment:
Behavioral: Remind-to-move
Modified constraint induced movement therapy (mCIMT)
Active Comparator group
Description:
children were encouraged to wear a customer-made volar resting splint that extended from below the elbow to the fingertips on their noninvolved hands for 5 hour daily except for toileting, writing and specific physical sports, for 3 weeks. Each child was supervised by one therapist to complete structured unimanual practice with the affected hand during the supervised session, 5 days every week, for 3 consecutive weeks.
Treatment:
Behavioral: Modified constraint induced movement therapy
Conventional rehabilitation
Placebo Comparator group
Description:
Conventional splinting, muscle strengthening, stretching, and neurodevelopmental facilitation techniques for 1hr daily, 2 day per week for 3 weeks.
Treatment:
Behavioral: Conventional rehabilitation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems